Clinical Trials Browser

Phase EARLY_PHASE1 × Primary Malignant Peripheral Nerve Sheath Tumors × 30 days × Clear all

NCT06693284 2026-05-29

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]

Phase EARLY_PHASE1 Recruiting

Primary Malignant Peripheral Nerve Sheath Tumors